Schwabe Stefan K.F.

Executive Vice President & CMO at SUPERNUS PHARMACEUTICALS, INC.

Sold, on record
$10.1M
Dollars the filings state
Form 4 sales
8
Latest Dec 21, 2020
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.Unusual
    Jun 11, 2015 2015

    Sold 3,631 shares at $16.40 ($60k)

    Schwabe Stefan K.F., Executive Vice President R&D

    Sold 42.8% of holdings ($139k position)4,845 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.Unusual
    Jun 12, 2015 +1 day

    Sold 2,051 shares at $18.27 ($37k)

    Schwabe Stefan K.F., Executive Vice President R&D

    Sold 42.3% of holdings ($89k position)2,794 shares leftFiling

  3. 3 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.Unusual
    Jul 13, 2015 +31 days

    Sold 1,950 shares at $19.23 ($37k)

    Schwabe Stefan K.F., Executive Vice President R&D

    Sold 69.8% of holdings ($54k position)844 shares leftFiling

  4. 4 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.Unusual
    Jul 28, 2015 +15 days

    Sold 2,350 shares at $21.20 ($50k)

    Schwabe Stefan K.F., Executive Vice President R&D

    Sold 100% of holdings ($50k position)0 shares left1.1x usual sizeFiling

  5. 5 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.Unusual
    Sep 7, 2017 +772 days

    Sold 95,000 shares at $46.59 ($4.4M)

    Schwabe Stefan K.F., Executive Vice President R&D

    Sold 98.1% of holdings ($4.5M position)1,855 shares leftFirst sale on recordFiling

  6. 6 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.Unusual
    Jun 18, 2018 +284 days

    Sold 60,000 shares at $54.39 ($3.3M)

    Schwabe Stefan K.F., Executive VP R&D, CMO

    Sold 96.8% of holdings ($3.4M position)1,967 shares leftFiling

  7. 7 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.Unusual
    Dec 14, 2020 +910 days

    Sold 53,653 shares at $21.87 ($1.2M)

    Schwabe Stefan K.F., Executive Vice President & CMO

    Sold 95.1% of holdings ($1.2M position)2,772 shares leftFirst sale on recordFiling

  8. 8 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.Unusual
    Dec 21, 2020 +7 days

    Sold 46,347 shares at $22.10 ($1M)

    Schwabe Stefan K.F., Executive Vice President & CMO

    Sold 94.4% of holdings ($1.1M position)2,772 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by Schwabe Stefan K.F.
Source
Dec 21, 2020Dec 22, 2020SUPERNUS PHARMACEUTICALS, INC.Executive Vice President & CMOForm 4 sale46,347$1M94.4%UnusualSEC
Dec 14, 2020Dec 15, 2020SUPERNUS PHARMACEUTICALS, INC.Executive Vice President & CMOForm 4 sale53,653$1.2M95.1%UnusualSEC
Jun 18, 2018Jun 19, 2018SUPERNUS PHARMACEUTICALS, INC.Executive VP R&D, CMOForm 4 sale60,000$3.3M96.8%UnusualSEC
Sep 7, 2017Sep 11, 2017SUPERNUS PHARMACEUTICALS, INC.Executive Vice President R&DForm 4 sale95,000$4.4M98.1%UnusualSEC
Jul 28, 2015Jul 29, 2015SUPERNUS PHARMACEUTICALS, INC.Executive Vice President R&DForm 4 sale2,350$50k100.0%UnusualSEC
Jul 13, 2015Jul 14, 2015SUPERNUS PHARMACEUTICALS, INC.Executive Vice President R&DForm 4 sale1,950$37k69.8%UnusualSEC
Jun 12, 2015Jun 15, 2015SUPERNUS PHARMACEUTICALS, INC.Executive Vice President R&DForm 4 sale2,051$37k42.3%UnusualSEC
Jun 11, 2015Jun 12, 2015SUPERNUS PHARMACEUTICALS, INC.Executive Vice President R&DForm 4 sale3,631$60k42.8%UnusualSEC